Ignite Creation Date:
2024-05-06 @ 3:05 PM
Last Modification Date:
2024-10-26 @ 1:42 PM
Study NCT ID:
NCT04513028
Status:
RECRUITING
Last Update Posted:
2024-05-24
First Post:
2020-07-30
Brief Title:
Beta Glucans Effect on Pembrolizumab Immunologic Response in Stage III-IV Melanoma
Sponsor:
Kelly McMasters
Organization:
University of Louisville
Organization Data
Organization:
University of Louisville
Class:
OTHER
Study ID:
200614
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Kelly McMasters
Lead Sponsor Class:
OTHER
Responsible Party:
Kelly McMasters
Responsible Party Title:
Principal Investigator
Responsible Party Type:
SPONSOR_INVESTIGATOR
Responsible Party Affiliation:
University of Louisville
Old Name:
None
Old Organization:
None